|
Insider Trading: Genomic Health Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Genomic Health Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Genomic Health Inc since year 2005. Table 2 shows the detailed insider transactions of Genomic Health Inc since 2005.
The reporting company's ticker symbol is GHDX.
The reporting company's CIK number is 1131324.
The total value of stock buying since 2005 is $402,130,668.
The total value of stock sales is $49,674,467.
The total value of stock exercises is $3,543,113.
1 year stock price chart,
1 day stock price chart
GHDX 1 year chart GHDX 1 day chart
Figure 1. Monthly insider transaction values at Genomic Health Inc (GHDX) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
06 07 08 09 10 11 12 01 2012 02 03 04 05 06 07 08 09 10 11 12 01 2013 02 03 04 05 -
Figure 2. Average prices of insider buys, sales, and option exercises at Genomic Health Inc (GHDX) in the past 24 months. See table 2 for insider transaction details.
06 07 08 09 10 11 12 01 2012 02 03 04 05 06 07 08 09 10 11 12 01 2013 02 03 04 05 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Genomic Health Inc (GHDX).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2013-05 | 311,865 | 10,901,379 | 14,087 | 498,492 | 14,087 | 114,556 |
| 2013-04 | 0 | 0 | 5,000 | 144,482 | 5,000 | 10,525 |
| 2013-03 | 0 | 0 | 2,500 | 71,435 | 2,500 | 3,325 |
| 2013-02 | 217,445 | 6,119,759 | 46,466 | 1,318,016 | 43,750 | 781,960 |
| 2013-01 | 0 | 0 | 7,125 | 200,739 | 7,125 | 30,627 |
| 2012-12 | 0 | 0 | 15,500 | 431,107 | 5,500 | 31,495 |
| 2012-11 | 1,156,239 | 31,525,505 | 48,116 | 1,306,607 | 7,500 | 34,149 |
| 2012-10 | 0 | 0 | 21,750 | 736,466 | 11,750 | 174,382 |
| 2012-09 | 0 | 0 | 12,500 | 414,765 | 2,500 | 3,325 |
| 2012-08 | 0 | 0 | 34,000 | 1,180,157 | 32,250 | 372,570 |
| 2012-07 | 0 | 0 | 46,600 | 1,652,117 | 6,600 | 54,930 |
| 2012-06 | 0 | 0 | 42,500 | 1,429,860 | 2,500 | 3,325 |
| 2012-05 | 854,973 | 26,965,075 | 74,794 | 2,398,312 | 7,500 | 119,875 |
| 2012-04 | 0 | 0 | 35,500 | 1,013,613 | 4,500 | 5,979 |
| 2012-03 | 428,145 | 12,789,188 | 63,500 | 1,939,635 | 2,500 | 3,325 |
| 2012-02 | 1,846,592 | 52,044,225 | 38,255 | 1,037,135 | 2,500 | 3,325 |
| 2012-01 | 0 | 0 | 40,500 | 1,103,159 | 4,500 | 5,979 |
| 2011-12 | 304,071 | 8,528,204 | 27,500 | 753,560 | 2,500 | 3,325 |
| 2011-11 | 1,415,609 | 37,478,369 | 27,500 | 741,665 | 7,500 | 50,275 |
| 2011-10 | 0 | 0 | 32,000 | 721,125 | 12,000 | 56,254 |
| 2011-09 | 0 | 0 | 27,500 | 569,710 | 7,500 | 50,275 |
| 2011-08 | 0 | 0 | 27,500 | 666,981 | 7,500 | 50,275 |
| 2011-07 | 0 | 0 | 32,000 | 876,856 | 12,000 | 56,254 |
| 2011-06 | 491,170 | 12,969,827 | 28,500 | 740,781 | 7,500 | 50,275 |
| 2011-05 | 116,208 | 3,167,096 | 28,500 | 752,196 | 7,500 | 50,275 |
| 2011-04 | 0 | 0 | 41,000 | 1,061,996 | 15,000 | 124,724 |
| 2011-03 | 1,019,260 | 25,953,993 | 70,820 | 1,789,399 | 13,000 | 122,070 |
| 2011-02 | 85,476 | 2,144,763 | 34,000 | 762,991 | 18,000 | 183,495 |
| 2011-01 | 0 | 0 | 34,276 | 741,307 | 14,276 | 33,364 |
| 2010-12 | 0 | 0 | 30,500 | 687,520 | 10,500 | 26,365 |
| 2010-11 | 0 | 0 | 30,500 | 550,440 | 60,500 | 542,865 |
| 2010-10 | 0 | 0 | 20,000 | 279,000 | 0 | 0 |
| 2010-09 | 51,342 | 745,705 | 30,234 | 451,764 | 10,234 | 25,598 |
| 2010-08 | 864,973 | 12,611,379 | 35,129 | 520,597 | 10,500 | 26,365 |
| 2010-07 | 0 | 0 | 24,629 | 316,583 | 0 | 0 |
| 2010-06 | 0 | 0 | 24,629 | 347,952 | 0 | 0 |
| 2010-05 | 0 | 0 | 35,129 | 550,000 | 10,500 | 26,365 |
| 2010-04 | 0 | 0 | 29,629 | 500,051 | 5,000 | 6,650 |
| 2010-03 | 0 | 0 | 153,829 | 2,990,247 | 2,500 | 3,325 |
| 2010-02 | 500,088 | 8,496,802 | 27,129 | 467,639 | 2,500 | 3,325 |
| 2010-01 | 0 | 0 | 9,629 | 167,114 | 5,000 | 6,650 |
| 2009-12 | 0 | 0 | 28,629 | 580,159 | 0 | 0 |
| 2009-11 | 0 | 0 | 37,294 | 730,015 | 665 | 884 |
| 2009-10 | 0 | 0 | 26,629 | 551,250 | 0 | 0 |
| 2009-09 | 0 | 0 | 26,629 | 550,538 | 0 | 0 |
| 2009-08 | 360,972 | 7,116,249 | 31,629 | 624,684 | 5,000 | 6,650 |
| 2009-07 | 0 | 0 | 4,629 | 74,114 | 0 | 0 |
| 2009-06 | 0 | 0 | 10,629 | 191,497 | 0 | 0 |
| 2009-05 | 321,783 | 6,216,101 | 26,629 | 520,450 | 0 | 0 |
| 2009-04 | 0 | 0 | 16,629 | 425,350 | 0 | 0 |
| 2009-03 | 0 | 0 | 16,629 | 321,343 | 0 | 0 |
| 2009-02 | 0 | 0 | 21,629 | 455,022 | 5,000 | 6,650 |
| 2009-01 | 0 | 0 | 4,629 | 89,858 | 0 | 0 |
| 2008-12 | 0 | 0 | 16,729 | 311,955 | 69,348 | 219,833 |
| 2008-11 | 0 | 0 | 26,629 | 535,565 | 10,000 | 13,300 |
| 2008-10 | 0 | 0 | 25,887 | 553,977 | 0 | 0 |
| 2008-09 | 0 | 0 | 30,887 | 691,589 | 0 | 0 |
| 2008-08 | 0 | 0 | 55,927 | 1,330,867 | 5,000 | 6,650 |
| 2008-07 | 0 | 0 | 16,629 | 341,136 | 0 | 0 |
| 2008-06 | 493,611 | 9,796,688 | 16,729 | 324,292 | 0 | 0 |
| 2008-05 | 0 | 0 | 16,629 | 314,159 | 0 | 0 |
| 2008-04 | 0 | 0 | 12,000 | 206,658 | 0 | 0 |
| 2008-03 | 0 | 0 | 16,629 | 320,821 | 0 | 0 |
| 2008-02 | 0 | 0 | 30,629 | 686,732 | 10,201 | 9,645 |
| 2008-01 | 0 | 0 | 16,629 | 411,393 | 0 | 0 |
| 2007-12 | 0 | 0 | 4,629 | 106,906 | 0 | 0 |
| 2007-11 | 0 | 0 | 11,284 | 253,849 | 0 | 0 |
| 2007-10 | 0 | 0 | 16,629 | 333,777 | 0 | 0 |
| 2007-09 | 0 | 0 | 40,629 | 799,617 | 0 | 0 |
| 2007-08 | 5,350 | 100,387 | 16,629 | 328,861 | 0 | 0 |
| 2007-07 | 0 | 0 | 16,629 | 342,235 | 0 | 0 |
| 2007-06 | 0 | 0 | 16,629 | 311,131 | 0 | 0 |
| 2007-05 | 4,000,143 | 64,065,260 | 16,629 | 274,912 | 0 | 0 |
| 2007-04 | 0 | 0 | 16,629 | 286,649 | 43,345 | 27,480 |
| 2007-03 | 628,786 | 11,484,376 | 16,629 | 304,353 | 0 | 0 |
| 2007-02 | 811,781 | 14,845,020 | 16,629 | 305,182 | 0 | 0 |
| 2006-12 | 953,338 | 19,285,985 | 0 | 0 | 0 | 0 |
| 2006-09 | 1,195,954 | 16,779,333 | 0 | 0 | 0 | 0 |
Go to page: 1
2
3
4
Table 2. Detailed insider stock purchases, sales, and option exercises
for Genomic Health Inc (GHDX)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2013-05-16 | Baker Bros Advisors Llc (Director) | Purchase | 19,306 | 36.54 | 705,421 |
| 2013-05-15 | Baker Bros Advisors Llc (Director) | Purchase | 52,133 | 36.41 | 1,898,371 |
| 2013-05-15 | Livingston Randall S (Director) | Sale | 1,337 | 35.83 | 47,903 |
| 2013-05-15 | Livingston Randall S (Director) | Option Exercise | 1,337 | 1.33 | 1,774 |
| 2013-05-14 | Baker Bros Advisors Llc (Director) | Purchase | 27,184 | 35.53 | 965,901 |
| 2013-05-13 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 34.70 | 173,505 |
| 2013-05-13 | Popovits Kimberly J (President and CEO) | Option Exercise | 5,000 | 2.88 | 14,400 |
| 2013-05-13 | Hibbs Kathy L (SVP & General Counsel) | Sale | 1,250 | 34.42 | 43,031 |
| 2013-05-13 | Hibbs Kathy L (SVP & General Counsel) | Option Exercise | 1,250 | 21.07 | 26,337 |
| 2013-05-13 | Baker Bros Advisors Llc (Director) | Purchase | 213,242 | 34.38 | 7,331,686 |
| 2013-05-09 | Schorno Dean L (CFO) | Sale | 4,000 | 36.02 | 144,088 |
| 2013-05-09 | Schorno Dean L (CFO) | Option Exercise | 4,000 | 17.18 | 68,720 |
| 2013-05-08 | Cole G Bradley (COO) | Sale | 2,500 | 35.99 | 89,965 |
| 2013-05-08 | Cole G Bradley (COO) | Option Exercise | 2,500 | 1.33 | 3,325 |
| 2013-04-23 | Popovits Kimberly J (President and CEO) | Sale | 2,500 | 30.00 | 75,000 |
| 2013-04-23 | Popovits Kimberly J (President and CEO) | Option Exercise | 2,500 | 2.88 | 7,200 |
| 2013-04-03 | Cole G Bradley (COO) | Sale | 2,500 | 27.79 | 69,482 |
| 2013-04-03 | Cole G Bradley (COO) | Option Exercise | 2,500 | 1.33 | 3,325 |
| 2013-03-06 | Cole G Bradley (COO) | Sale | 2,500 | 28.57 | 71,435 |
| 2013-03-06 | Cole G Bradley (COO) | Option Exercise | 2,500 | 1.33 | 3,325 |
| 2013-02-21 | Baker Bros Advisors Llc (Director) | Purchase | 28,200 | 27.64 | 779,335 |
| 2013-02-20 | Hibbs Kathy L (SVP & General Counsel) | Sale | 2,716 | 28.13 | 76,398 |
| 2013-02-20 | Baker Bros Advisors Llc (Director) | Purchase | 20,885 | 27.97 | 584,216 |
| 2013-02-14 | Baker Bros Advisors Llc (Director) | Purchase | 34,800 | 28.43 | 989,398 |
| 2013-02-14 | Myers Woodrow A Jr (Director) | Sale | 41,250 | 28.40 | 1,171,541 |
| 2013-02-14 | Myers Woodrow A Jr (Director) | Option Exercise | 41,250 | 18.88 | 778,635 |
| 2013-02-13 | Baker Bros Advisors Llc (Director) | Purchase | 17,200 | 28.58 | 491,593 |
| 2013-02-11 | Baker Bros Advisors Llc (Director) | Purchase | 79,984 | 28.23 | 2,258,108 |
| 2013-02-08 | Baker Bros Advisors Llc (Director) | Purchase | 36,376 | 27.96 | 1,017,109 |
| 2013-02-06 | Cole G Bradley (COO) | Sale | 2,500 | 28.03 | 70,077 |
| 2013-02-06 | Cole G Bradley (COO) | Option Exercise | 2,500 | 1.33 | 3,325 |
| 2013-01-28 | Livingston Randall S (Director) | Sale | 2,000 | 28.77 | 57,544 |
| 2013-01-28 | Livingston Randall S (Director) | Option Exercise | 2,000 | 1.33 | 2,654 |
| 2013-01-09 | Schorno Dean L (CFO) | Sale | 2,625 | 28.00 | 73,500 |
| 2013-01-09 | Schorno Dean L (CFO) | Option Exercise | 2,625 | 9.39 | 24,648 |
| 2013-01-09 | Cole G Bradley (COO) | Sale | 2,500 | 27.88 | 69,695 |
| 2013-01-09 | Cole G Bradley (COO) | Option Exercise | 2,500 | 1.33 | 3,325 |
| 2012-12-18 | Shak Steven (EVP of R&D & CMO) | Sale | 5,000 | 27.74 | 138,720 |
| 2012-12-13 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 28.09 | 140,440 |
| 2012-12-11 | Schorno Dean L (CFO) | Sale | 3,000 | 28.00 | 84,000 |
| 2012-12-11 | Schorno Dean L (CFO) | Option Exercise | 3,000 | 9.39 | 28,170 |
| 2012-12-06 | Cole G Bradley (COO) | Sale | 2,500 | 27.18 | 67,947 |
| 2012-12-06 | Cole G Bradley (COO) | Option Exercise | 2,500 | 1.33 | 3,325 |
| 2012-11-26 | Livingston Randall S (Director) | Sale | 2,000 | 27.84 | 55,684 |
| 2012-11-26 | Livingston Randall S (Director) | Option Exercise | 2,000 | 1.33 | 2,654 |
| 2012-11-21 | Baker Bros Advisors Llc (Director) | Purchase | 300 | 27.54 | 8,262 |
| 2012-11-20 | Shak Steven (EVP of R&D & CMO) | Sale | 5,000 | 27.17 | 135,845 |
| 2012-11-20 | Baker Bros Advisors Llc (Director) | Purchase | 229,000 | 26.83 | 6,143,383 |
| 2012-11-20 | Colella Samuel D (Director) | Sale | 5,500 | 26.52 | 145,843 |
| 2012-11-19 | Colella Samuel D (Director) | Sale | 25,116 | 26.97 | 677,478 |
| 2012-11-14 | 667, L.p. (Director) | Purchase | 103,167 | 27.32 | 2,818,212 |
| 2012-11-14 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 27.24 | 136,215 |
| 2012-11-13 | 667, L.p. (Director) | Purchase | 103,839 | 27.99 | 2,906,661 |
| 2012-11-12 | 667, L.p. (Director) | Purchase | 200,000 | 27.94 | 5,587,400 |
| 2012-11-12 | Schorno Dean L (CFO) | Sale | 2,800 | 28.00 | 78,400 |
| 2012-11-12 | Schorno Dean L (CFO) | Option Exercise | 2,800 | 9.39 | 26,292 |
| 2012-11-09 | 667, L.p. (Director) | Purchase | 519,933 | 27.04 | 14,061,587 |
| 2012-11-09 | Schorno Dean L (CFO) | Sale | 200 | 28.00 | 5,600 |
| 2012-11-09 | Schorno Dean L (CFO) | Option Exercise | 200 | 9.39 | 1,878 |
| 2012-11-08 | Cole G Bradley (COO) | Sale | 2,500 | 28.62 | 71,542 |
| 2012-11-08 | Cole G Bradley (COO) | Option Exercise | 2,500 | 1.33 | 3,325 |
| 2012-10-16 | Shak Steven (EVP of R&D & CMO) | Sale | 5,000 | 35.01 | 175,055 |
| 2012-10-16 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 35.00 | 175,000 |
| 2012-10-16 | Popovits Kimberly J (President and CEO) | Option Exercise | 5,000 | 23.31 | 116,550 |
| 2012-10-15 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 31.17 | 155,840 |
| 2012-10-12 | Schorno Dean L (CFO) | Sale | 3,000 | 33.79 | 101,358 |
| 2012-10-12 | Schorno Dean L (CFO) | Option Exercise | 3,000 | 9.39 | 28,170 |
| 2012-10-11 | Hibbs Kathy L (SVP & General Counsel) | Sale | 1,250 | 33.78 | 42,223 |
| 2012-10-11 | Hibbs Kathy L (SVP & General Counsel) | Option Exercise | 1,250 | 21.07 | 26,337 |
| 2012-10-09 | Cole G Bradley (COO) | Sale | 2,500 | 34.80 | 86,990 |
| 2012-10-09 | Cole G Bradley (COO) | Option Exercise | 2,500 | 1.33 | 3,325 |
| 2012-09-18 | Shak Steven (EVP of R&D & CMO) | Sale | 5,000 | 33.76 | 168,800 |
| 2012-09-13 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 31.69 | 158,450 |
| 2012-09-06 | Cole G Bradley (COO) | Sale | 2,500 | 35.01 | 87,515 |
| 2012-09-06 | Cole G Bradley (COO) | Option Exercise | 2,500 | 1.33 | 3,325 |
| 2012-08-21 | Myers Woodrow A Jr (Director) | Sale | 10,993 | 35.28 | 387,800 |
| 2012-08-21 | Myers Woodrow A Jr (Director) | Option Exercise | 10,993 | 9.95 | 109,380 |
| 2012-08-20 | Shak Steven (EVP of R&D & CMO) | Sale | 5,000 | 34.99 | 174,940 |
| 2012-08-20 | Myers Woodrow A Jr (Director) | Sale | 5,507 | 35.06 | 193,058 |
| 2012-08-20 | Myers Woodrow A Jr (Director) | Option Exercise | 5,507 | 9.95 | 54,794 |
| 2012-08-14 | Popovits Kimberly J (President and CEO) | Sale | 3,103 | 35.07 | 108,812 |
| 2012-08-14 | Popovits Kimberly J (President and CEO) | Option Exercise | 3,103 | 23.31 | 72,330 |
| 2012-08-13 | Popovits Kimberly J (President and CEO) | Sale | 6,897 | 34.70 | 239,312 |
| 2012-08-13 | Popovits Kimberly J (President and CEO) | Option Exercise | 1,897 | 23.31 | 44,219 |
| 2012-08-08 | Cole G Bradley (COO) | Sale | 2,500 | 30.49 | 76,235 |
| 2012-08-08 | Cole G Bradley (COO) | Option Exercise | 2,500 | 1.33 | 3,325 |
| 2012-08-01 | Cohen Fred E (Director) | Option Exercise | 8,250 | 10.73 | 88,522 |
| 2012-07-26 | Livingston Randall S (Director) | Sale | 2,000 | 35.90 | 71,800 |
| 2012-07-26 | Livingston Randall S (Director) | Option Exercise | 2,000 | 1.33 | 2,654 |
| 2012-07-24 | Shak Steven (Chief Medical Officer) | Sale | 5,000 | 34.24 | 171,195 |
| 2012-07-13 | Popovits Kimberly J (President and CEO) | Sale | 7,100 | 34.84 | 247,342 |
| 2012-07-13 | Popovits Kimberly J (President and CEO) | Option Exercise | 2,100 | 23.31 | 48,951 |
| 2012-07-11 | Scott Randal W (CEO, InVitae Corporation*) | Sale | 15,000 | 35.16 | 527,340 |
| 2012-07-10 | Scott Randal W (CEO, InVitae Corporation*) | Sale | 15,000 | 36.30 | 544,575 |
| 2012-07-05 | Cole G Bradley (COO) | Sale | 2,500 | 35.95 | 89,865 |
| 2012-07-05 | Cole G Bradley (COO) | Option Exercise | 2,500 | 1.33 | 3,325 |
| 2012-06-25 | Shak Steven (Chief Medical Officer) | Sale | 5,000 | 33.25 | 166,250 |
| 2012-06-13 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 33.36 | 166,805 |
| 2012-06-12 | Scott Randal W (CEO, InVitae Corporation*) | Sale | 15,000 | 33.31 | 499,650 |
| 2012-06-11 | Scott Randal W (CEO, InVitae Corporation*) | Sale | 15,000 | 34.15 | 512,235 |
| 2012-06-06 | Cole G Bradley (COO) | Sale | 2,500 | 33.97 | 84,920 |
| 2012-06-06 | Cole G Bradley (COO) | Option Exercise | 2,500 | 1.33 | 3,325 |
| 2012-05-31 | Popovits Kimberly J (President and CEO) | Purchase | 919 | 23.11 | 21,239 |
| 2012-05-24 | Shak Steven (Chief Medical Officer) | Sale | 5,000 | 33.80 | 168,980 |
| 2012-05-22 | Baker Felix (Director) | Purchase | 17,406 | 32.94 | 573,405 |
| 2012-05-21 | Baker Felix (Director) | Purchase | 150,000 | 32.12 | 4,818,450 |
| 2012-05-18 | Colella Samuel D (Director) | Sale | 9,300 | 32.13 | 298,790 |
| 2012-05-17 | Colella Samuel D (Director) | Sale | 16,994 | 33.52 | 569,689 |
| 2012-05-16 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 35.00 | 175,000 |
| 2012-05-16 | Popovits Kimberly J (President and CEO) | Option Exercise | 5,000 | 23.31 | 116,550 |
| 2012-05-16 | Baker Felix (Director) | Purchase | 23,621 | 34.46 | 813,932 |
| 2012-05-15 | Schorno Dean L (CFO) | Sale | 1,000 | 33.69 | 33,686 |
| 2012-05-15 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 33.46 | 167,290 |
| 2012-05-15 | Baker Felix (Director) | Purchase | 140,000 | 33.94 | 4,752,160 |
| 2012-05-14 | Baker Felix (Director) | Purchase | 212,438 | 32.92 | 6,994,521 |
| 2012-05-11 | Scott Randal W (CEO, InVitae Corporation*) | Sale | 15,000 | 30.74 | 461,145 |
| 2012-05-11 | Baker Felix (Director) | Purchase | 26,660 | 30.22 | 805,558 |
| 2012-05-10 | Scott Randal W (CEO, InVitae Corporation*) | Sale | 15,000 | 30.10 | 451,560 |
| 2012-05-10 | Baker Felix (Director) | Purchase | 68,681 | 29.92 | 2,054,798 |
| 2012-05-09 | Cole G Bradley (COO) | Sale | 2,500 | 28.87 | 72,172 |
| 2012-05-09 | Cole G Bradley (COO) | Option Exercise | 2,500 | 1.33 | 3,325 |
| 2012-05-09 | Baker Felix (Director) | Purchase | 19,547 | 29.90 | 584,357 |
| 2012-05-08 | Baker Felix (Director) | Purchase | 86,033 | 28.60 | 2,460,543 |
| 2012-05-07 | Baker Felix (Director) | Purchase | 56,540 | 28.26 | 1,598,103 |
| 2012-05-04 | Baker Felix (Director) | Purchase | 53,128 | 28.01 | 1,488,009 |
| 2012-04-26 | Livingston Randall S (Director) | Sale | 2,000 | 28.21 | 56,428 |
| 2012-04-26 | Livingston Randall S (Director) | Option Exercise | 2,000 | 1.33 | 2,654 |
| 2012-04-24 | Shak Steven (Chief Medical Officer) | Sale | 5,000 | 27.93 | 139,630 |
| 2012-04-23 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 27.79 | 138,965 |
| 2012-04-16 | Schorno Dean L (CFO) | Sale | 1,000 | 27.98 | 27,980 |
| 2012-04-11 | Scott Randal W (CEO, InVitae Corporation*) | Sale | 10,000 | 28.38 | 283,790 |
| 2012-04-10 | Scott Randal W (CEO, InVitae Corporation*) | Sale | 10,000 | 29.11 | 291,130 |
| 2012-04-04 | Cole G Bradley (COO) | Sale | 2,500 | 30.28 | 75,690 |
| 2012-04-04 | Cole G Bradley (COO) | Option Exercise | 2,500 | 1.33 | 3,325 |
| 2012-03-22 | Shak Steven (Chief Medical Officer) | Sale | 10,000 | 30.08 | 300,830 |
| 2012-03-22 | Popovits Kimberly J (President and CEO) | Sale | 10,000 | 30.07 | 300,670 |
| 2012-03-15 | Schorno Dean L (CFO) | Sale | 1,000 | 31.08 | 31,080 |
| 2012-03-13 | Scott Randal W (CEO, InVitae Corporation) | Sale | 15,000 | 31.12 | 466,770 |
| 2012-03-12 | Scott Randal W (CEO, InVitae Corporation) | Sale | 15,000 | 30.98 | 464,685 |
| 2012-03-08 | Cole G Bradley (COO) | Sale | 2,500 | 29.94 | 74,850 |
| 2012-03-08 | Cole G Bradley (COO) | Option Exercise | 2,500 | 1.33 | 3,325 |
| 2012-03-08 | Baker Felix (Director) | Purchase | 22,191 | 30.36 | 673,805 |
| 2012-03-07 | Baker Felix (Director) | Purchase | 25,000 | 29.88 | 746,974 |
| 2012-03-05 | Baker Felix (Director) | Purchase | 177,710 | 30.01 | 5,333,432 |
| 2012-03-02 | Baker Felix (Director) | Purchase | 104,850 | 29.52 | 3,095,170 |
| 2012-03-01 | Baker Felix (Director) | Purchase | 17,456 | 29.47 | 514,427 |
| 2012-02-29 | Baker Felix (Director) | Purchase | 180,603 | 29.06 | 5,247,961 |
| 2012-02-28 | Baker Felix (Director) | Purchase | 58,535 | 29.11 | 1,703,835 |
| 2012-02-27 | Baker Felix (Director) | Purchase | 42,125 | 29.03 | 1,222,930 |
| 2012-02-24 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 28.85 | 144,255 |
Go to page: 1
2
3
4
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Genomic Health Inc (symbol GHDX,
CIK number 1131324) see
the Securities and Exchange Commission (SEC) website.
|
|
